EQUITY (Tables)
|
3 Months Ended |
12 Months Ended |
Mar. 31, 2024 |
Dec. 31, 2023 |
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
|
| SCHEDULE OF STOCK WARRANTS OUTSTANDING TO PURCHASE COMMON STOCK |
As
of March 31, 2024, the Company had the following outstanding warrants to purchase common stock:
SCHEDULE
OF STOCK WARRANTS OUTSTANDING TO PURCHASE COMMON STOCK
| Warrant | |
Issuance Date | |
Expiration Date | |
Exercise Price Per Share ($) | | |
Number of Shares of common stock Underlying Warrants | |
| | |
| |
| |
| | |
| |
| March 2021 Warrant | |
March 29, 2021 | |
March 31, 2026 | |
| 10.35 | | |
| 2,469,156 | |
| March 2023 Warrant | |
March 27, 2023 | |
March 26, 2026 | |
| 5.50 | | |
| 3,294,117 | |
| | |
| |
| |
| | | |
| 5,763,273 | |
|
As
of December 31, 2023, the Company had the following outstanding warrants to purchase common stock:
SCHEDULE
OF STOCK WARRANTS OUTSTANDING TO PURCHASE COMMON STOCK
| | | |
| | |
| | |
| | |
Number of | |
| | | |
| | |
| | |
| | |
Shares of | |
| | | |
| | |
| | |
Exercise Price | | |
common stock | |
| | | |
Issuance | | |
Expiration | | |
Per Share | | |
Underlying | |
| Warrant | | |
Date | | |
Date | | |
($) | | |
Warrants | |
| | | |
| | |
| | |
| | |
| |
| March 2021 Warrant | | |
March 29, 2021 | | |
| March
31, 2026 | | |
| 10.35 | | |
| 2,469,156 | |
| March
2023 Warrant | | |
March 27, 2023 | | |
| March
26, 2026 | | |
| 5.50 | | |
| 3,294,117 | |
| | | |
| | | |
| | | |
| | | |
| 5,763,273 | |
|
| SCHEDULE OF STOCK OPTION ACTIVITY |
The
following table summarizes stock option activity for the three months ended March 31, 2024:
SCHEDULE
OF STOCK OPTION ACTIVITY
| | |
For the
Three months ended
March 31, 2024 | |
| | |
Amount of options | | |
Weighted average exercise price | |
| | |
| | | |
$ | |
| Outstanding at beginning of period | |
| 2,455,069 | | |
| 3.46 | |
| Granted | |
| - | | |
| - | |
| Forfeited | |
| - | | |
| - | |
| Outstanding at end of period | |
| 2,455,069 | | |
| 3.46 | |
| | |
| | | |
| | |
| Vested at end of period | |
| 1,245,669 | | |
| 3.46 | |
|
The
following summarizes stock option activity:
SCHEDULE
OF STOCK OPTION ACTIVITY
| | |
Amount
of options | | |
Weighted
average exercise price | | |
Weighted
Average Remaining Contractual Term (years) | | |
Aggregate
Intrinsic Value (in thousands) | |
| | |
| | |
$ | | |
| | |
$
in thousands | |
| Outstanding - January 1, 2022 | |
| 1,253,554 | | |
| 3.31 | | |
| 5.65 | | |
| 5,884 | |
| Granted | |
| 479,000 | | |
| 4.50 | | |
| - | | |
| - | |
| Forfeited | |
| (172,514 | ) | |
| 3.57 | | |
| - | | |
| - | |
| Outstanding - December 31, 2022 | |
| 1,560,040 | | |
| 3.64 | | |
| 5.17 | | |
| 2,116 | |
| | |
| | | |
| | | |
| | | |
| | |
| Granted | |
| 986,000 | | |
| 3.15 | | |
| - | | |
| - | |
| Forfeited | |
| (90,971 | ) | |
| 3.28 | | |
| - | | |
| - | |
| Outstanding - December 31, 2023 | |
| 2,455,069 | | |
| 3.46 | | |
| 5.04 | | |
| 312 | |
| | |
| | | |
| | | |
| | | |
| | |
| Options Exercisable - December 31, 2023 | |
| 1,163,201 | | |
| 3.39 | | |
| 3.57 | | |
| 268 | |
|
| SCHEDULE OF STOCK-BASED PAYMENT EXPENSE |
The
following table sets forth the total stock-based payment expenses resulting from options and RSUs granted, included in the
statements of operation and comprehensive income:
SCHEDULE
OF STOCK-BASED PAYMENT EXPENSE
| | |
2024 | | |
2023 | |
| | |
Three months ended March 31, | |
| | |
2024 | | |
2023 | |
| | |
USD in thousands | |
| Cost of revenues | |
| 9 | | |
| 3 | |
| Research and development | |
| 135 | | |
| 140 | |
| Sales and marketing expenses | |
| 50 | | |
| 41 | |
| General and administrative | |
| 306 | | |
| 164 | |
| Total expenses | |
| 500 | | |
| 348 | |
|
The following table sets forth the total stock-based
payment expenses resulting from options and RSU granted, included in the statements of operation and comprehensive income:
SCHEDULE
OF STOCK-BASED PAYMENT EXPENSE
| | |
2023 | | |
2022 | |
| | |
Year ended on
December 31, | |
| | |
2023 | | |
2022 | |
| | |
USD in thousands | |
| Cost of revenues | |
| 22 | | |
| 29 | |
| Research and development | |
| 522 | | |
| 576 | |
| Sales and marketing expenses | |
| 126 | | |
| 130 | |
| General and administrative | |
| 994 | | |
| 903 | |
| Total expenses | |
| 1,664 | | |
| 1,638 | |
|
| Restricted Stock [Member] |
|
|
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] |
|
|
| SCHEDULE OF STOCK OPTION ACTIVITY |
The
following table summarizes RSU activity for the three months ended March 31, 2024:
SCHEDULE OF STOCK OPTION ACTIVITY
| | |
For the Three months ended March 31, 2024 | |
| | |
Amount of RSUs | | |
Weighted Average Grant Date Fair Value per Share | |
| | |
| | |
$ | |
| Outstanding at beginning of period | |
| 39,585 | | |
| 4.08 | |
| Granted | |
| - | | |
| - | |
| Forfeited | |
| - | | |
| - | |
| Vested | |
| (2,917 | ) | |
| 5.94 | |
| Unvested and Outstanding at end of period | |
| 36,668 | | |
| 3.94 | |
|
The
following table summarizes RSU activity for December 31, 2023:
SCHEDULE OF STOCK OPTION ACTIVITY
| | |
Amount of RSUs | | |
Weighted Average Grant Date Fair Value per Share | | |
Weighted Average Remaining Contractual Term (years) | |
| | |
| | |
$ | | |
| |
| Outstanding - December 31, 2022 | |
| 50,000 | | |
| 6.32 | | |
| 6.44 | |
| Granted | |
| 25,000 | | |
| 3 | | |
| - | |
| Forfeited | |
| (7,501 | ) | |
| 7.2 | | |
| | |
| Vested | |
| (27,914 | ) | |
| 6.28 | | |
| - | |
| Unvested and Outstanding - December 31, 2023 | |
| 39,585 | | |
| 4.08 | | |
| 6.30 | |
|